with one of the reasons potentially
being they are not receiving care on par
with men and white patients. The study
makes clear the disadvantage of these
groups and suggests that higher quality
of care for everyone might be a helpful
remedy.”
In a corresponding editorial comment, Jack V. Tu, MD, PhD, of the Institute for Clinical Evaluative Sciences, in
Toronto, Ontario, Canada, notes that the
analyses “reinforce the need to improve
the clinical presentation and treatment
of all AMI patients but especially those
of black race. They also demonstrate that
the sex differences in years of potential
life lost are primarily due to differences in life expectancy in the general
population rather than in the post-AMI
population.”
Bucholz EM, Normand ST, Wang Y, et al. J
Am Coll Cardiol. 2015;66(6):645-55.
Controlling CV Risk
Factors Benefits
Diabetes Patients
Control of multiple cardiovascular risk
factors with medication is feasible and
may help survival rates in patients
with type 2 diabetes mellitus (T2DM)
according to a study published Aug. 10
in JACC.
The study followed 2,265 patients
in the BARI 2D trial, which enrolled
patients with T2DM and stable coronary heart disease (CHD), with a mean
follow-up of 5 ± 1.4 years. Patients had
a mean duration of T2DM of 10 years
at baseline. Researchers then examined
the control of six risk factors: smoking
status, non–high-density lipoprotein
cholesterol (non-HDL-C) < 130 mg/
dL, triglycerides < 150 mg/dL,